论文部分内容阅读
目的研究探讨尿毒症患者中药配合透析前后心脏超声图的变化情况。方法选取尿毒症患者80例,透析前服用中药通脉口服液及大黄胶囊辅助透析,透析前后进行超声心动图检查,并对比分析相关数据。结果 80例患者中,65例患者在透析前存在左心室肥厚,占81.25%,其中46例伴有舒张功能减退,9例伴有收缩功能减退;57例患者在透析前存在左心室舒张功能减退,71.25%;15例患者在透析前存在左心室收缩功能减退,并同时伴有舒张功能减退,占18.75%。比较80例患者透析前后相关检测项目,其中LVDd、LAD、CI、CO、SV指标透析前后差异显著。进一步分析15例左心室收缩功能减退患者透析前后心功能变化情况,CI、FS、EF及SV在透析前后数值存在明显差异。结论尿毒症患者常伴有心血管疾病,其中左心室舒张障碍是引发尿毒症患者充血性心力衰竭的重要原因,通过中药配合透析治疗可以不同程度改变患者的心脏功能和结构,在一定程度上促进左心室收缩和舒张功能的恢复。
Objective To study the changes of echocardiography in patients with uremia before and after dialysis. Methods Eighty uremic patients were selected. Before dialysis, we took traditional Chinese medicine Tongmai oral solution and rhubarb capsule to assist dialysis. Echocardiography was performed before and after dialysis, and the related data were analyzed. Results Among 80 patients, 65 patients had left ventricular hypertrophy before dialysis, accounting for 81.25%. 46 patients had diastolic dysfunction and 9 patients had systolic dysfunction. Fifty-seven patients had left ventricular diastolic dysfunction , 71.25%; 15 patients had pre-dialysis left ventricular systolic dysfunction, accompanied by diastolic dysfunction, accounting for 18.75%. Pre-and post-dialysis-related test items were compared in 80 patients, of which LVDd, LAD, CI, CO and SV were significantly different before and after dialysis. Further analysis of 15 cases of left ventricular systolic dysfunction in patients before and after dialysis heart function changes, CI, FS, EF and SV values before and after dialysis there is a significant difference. Conclusions Uremic patients are often accompanied by cardiovascular diseases. Among them, left ventricular diastolic dysfunction is an important cause of congestive heart failure in patients with uremia. Through the combination of traditional Chinese medicine and dialysis, cardiac function and structure of patients can be changed to some extent, and to a certain extent, Ventricular systolic and diastolic function recovery.